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ABSTRACT 
Objective: Type 2 diabetes confers a greater excess risk of cardiovascular disease in women 
than in men. Diabetes is also a risk factor for dementia but whether the association is similar 
in women and men remains unknown. We performed a meta-analysis of unpublished data 
to estimate the sex-specific relationship between diabetes with incident dementia. 
 
Research Design and Methods: A systematic search identified studies published prior to 
November 2014 that had reported on the prospective association between diabetes and 
dementia. Study authors contributed unpublished sex-specific relative risks (RR) and 95% 
confidence intervals (95% CI) on the association between diabetes and all dementia and its 
subtypes. Sex-specific RRs and the women-to-men ratio of RRs (RRRs) were pooled using 
random-effects meta-analyses. 
 
Results: Study-level data from 14 studies, 2,310,330 individuals and 102 174 dementia cases 
were included. In multiple-adjusted analyses, diabetes was associated with 60% increased 
risk of any dementia in both sexes: pooled RR (95% CI) 1.62 (1.45-1.80) in women, and 1.58 
(1.38-1.81) in men, respectively.  The diabetes-associated RRs (95% CI) for vascular 
dementia were 2.34 (1.86-2.94) in women and 1.73 (1.61-1.85) in men, and for non-vascular 
dementia were 1.53 (1.35-1.73) in women and 1.49 (1.31-1.69) in men. Overall, women with 
diabetes had 19% greater risk of developing vascular dementia than men: multiple-adjusted 
RRR 1.19 (1.08-1.30) p<0.001.  
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Conclusions: Individuals with type 2 diabetes are at approximately 60% greater risk of 
developing dementia compared with those without diabetes. For vascular, but not for non-
vascular dementia, the additional risk is greater in women.  
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Dementia is a multi-faceted syndrome that lays claim to a growing burden of global disease: 
the most recent estimates suggest that there are approximately 44 million affected 
individuals worldwide and a further 7.7 million new cases annually.1, 2 Underpinned by a 
shifting demographic and associated epidemiological profile worldwide, the prevalence of 
dementia is forecast to nearly double by 2030, and to triple by 2050, and is set to create a 
significant economic, social and public health burden particularly in resource-poor 
countries.1, 2  
 
Non-vascular dementia, which mainly constitutes Alzheimer's disease (AD), and vascular 
dementia are the two most common forms of dementia, accounting for about 70% (25 
million) and 20% (7 million) of all dementia cases, respectively.
2
 Lifestyle risk factors 
including type 2 diabetes, cigarette smoking, and obesity are associated with an increased 
risk of developing both vascular dementia and non-vascular dementia in later life.3 For 
example, a review that included information on approximately 15,000 cases of dementia, 
found that, compared to non-affected individuals, those with diabetes had roughly 70% 
greater risk of developing dementia.
4
  
 
While of value, this review has some important limitations
4
: over 73% of dementia cases 
were derived from two large Asian cohorts,5, 6 and the influence of these studies on the 
overall summary estimates was not examined. Moreover, information on dementia 
subtypes was not universally available, including the single study that provided information 
on more than 50% of all dementia cases.
5
 Finally, as the analyses were not sex-specific it 
was not possible to determine whether the magnitude of the association between diabetes 
and incident dementia and its main subtypes differed in women and men. This is of interest 
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given the substantial amount of evidence suggesting that diabetes confers a significantly 
greater additional vascular hazard in women compared with men which potentially has 
ramifications for the clinical management of diabetes and vascular disease in women.7-9  
 
To overcome the substantial methodological limitations of past reviews, we requested 
individual study investigators to contribute unpublished results to a pooled analysis. In line 
with the current evidence base which suggests that diabetes poses more of a vascular 
hazard in women compared with men, our hypothesis was that diabetes confers a greater 
excess risk of vascular dementia in women than in men but that the impact of diabetes on 
risk of non-vascular dementia is similar between the sexes.   
 
RESEARCH DESIGN AND METHODS 
Search strategy and selection criteria 
We used PubMed MEDLINE (www.ncbi.nlm.nih.gov) and OVID MEDLINE for the period from 
January, 2011 to November, 2014 to identify studies that had reported on the association 
between diabetes and dementia in men and women from a general population. The search 
strategy combined the following text terms and MeSH: 'dementia', 'vascular dementia', 
'delirium', 'cognitive disorders', 'amnestic disorders', 'frontotemporal dementia', multi-
infarct dementia', 'Alzheimer disease', Lewy body', 'type 2 diabetes mellitus', 'diabetes 
mellitus', 'DM', 'diabetes complications', 'blood glucose', 'impaired glucose tolerance', 
'glycosylated hemoglobin', and 'prediabetes'. Studies prior to 2011 were identified from 
previous systematic reviews.
4, 10, 11
 Data from randomized trials were excluded due to the 
non-generalizable nature of trials to the general population. Two authors (SAEP and SC) 
conducted the literature search. Uncertainties regarding the identification of studies were 
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discussed and resolved by mutual consent. Since most studies did not publish estimates of 
relative risk separately for men and women or for dementia subtypes, and varied by which 
factors were included in adjusted models, we contacted authors of all the selected studies 
and asked them to provide additional results adjusted, where possible, for the same set of 
confounders: blood pressure, cigarette smoking, body mass index and total cholesterol. On 
a specifically designed form, contributing authors provided summary results for the age- and 
multiple-adjusted relative risks (RRs) and 95% confidence intervals (CIs) for any dementia, 
and if available, for vascular dementia and non-vascular dementia segregated by sex.  
 
Data extraction and statistical analysis 
The primary endpoints were incident all-cause dementia, vascular dementia, and non-
vascular dementia (as defined by the study investigators: see Supplementary Table 1). The 
primary metrics were the pooled multiple-adjusted RRs for dementia associated with 
diabetes and the women-to-men ratio of the RRs (RRR). Covariates that were included in the 
multiple-adjusted model were reported differently between studies and are shown in Table 
1. Age-adjusted estimates were used in a secondary analysis. From each study, we obtained 
the previously unpublished sex-specific RRs with accompanying 95% CIs for individuals with 
versus without diabetes. We also requested information on person-years of follow-up to 
calculate sex-specific incidence rates in individuals with and without diabetes. We log-
transformed these RRs and pooled them across studies using random effects meta-analysis 
with inverse variance weighting, and then exponentiated these values to obtain the pooled 
RR separately for women and men. We used similar methods to pool women-to-men ratio 
of RRs. For each study, we obtained the standard error of the log RRR by taking the square 
root of the sum of the variance of the two sex-specific log RRs. We used the I² statistic to 
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estimate the percentage of variability across studies due to between-study heterogeneity. In 
sensitivity analyses, we excluded estimates from two large cohort studies from Taiwan and 
Korea which had a large influence on the summary estimates.6, 12 We also examined 
whether restricting the analysis to those studies that used higher quality research criteria 
for dementia diagnosis (e.g. the Cross cultural Cognitive Examination, National Institute of 
Neurological and Communicative Disorders and Stroke, Alzheimer’s Disease and Related 
Disorders Association criteria) affected the main results.  We explored whether the 
background rate of dementia in the study population influenced the sex-specific 
associations by meta-regression analyses of the log RRR versus the difference in incidence 
rate between women with and without diabetes minus the equivalent estimate in men (i.e. 
the difference of the difference). We assessed the methodological quality of the studies 
using the Newcastle-Ottawa Scale (Supplementary methods).
13
 All analyses were performed 
using Stata version 12.0. 
 
RESULTS 
The systematic search identified 1495 unique articles that were subsequently examined on 
title and abstract (Supplementary Figure 1). Overall, 1425 articles were excluded for one or 
more reasons including lack of primary data, single-sex population, animal study, non-
prospective study design, and randomized trial of a high-risk population. Of the remaining 
articles, 70 articles qualified for full-text evaluation. Of these, 28 studies had relevant data 
on the relationship between diabetes and risk of dementia and the authors were contacted 
and asked to contribute additional estimates to those in the published reports. Authors 
from 13 studies (response 48%) contributed unpublished summary data,
12, 14-25
 and for one 
study we extracted the necessary data from its published report.
6
 The 14 non-contributing 
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studies comprised 30,900 individuals and 2,300 cases of dementia (Supplementary 
references) and the baseline characteristics are described in Table 1. Overall, data were 
available on 2,310,330 individuals (48% women) and 102,174 incident cases of dementia, 
including 9,253 cases of vascular dementia (52% women) and 90,233 cases of non-vascular 
dementia (58% women). Three cohorts were from Asia (90% of the individuals),
6, 12, 23
 four 
from Europe (9%),
16, 19, 24, 25
 and seven from the Americas (1%).
14, 15, 17, 18, 20-22
 The mean age 
of study participants ranged from 43 to 83 years, and the mean study duration ranged from 
two to 35 years across studies. The included studies were generally of good to very good 
quality (Supplementary Table 1). There was variation in the incidence rates for dementia 
between populations (Supplementary Table 2). 
 
Compared with not having diabetes, diabetes was significantly associated with 
approximately 60% increased risk of any dementia in both sexes; the multiple-adjusted 
pooled RR (95% CI) for any dementia associated with diabetes was 1.68 (1.64-1.71) in 
women and 1.61 (1.42-1.83) in men (Figures 1 and 2). There was moderate heterogeneity 
between studies in both women (I
2
=40%; p=0.065) and men (I
2
=48%, p=0.048). The size of 
the associations in women and men remained robust after excluding data, in turn, from the 
two large Asian cohorts (Supplementary Figure 2). Results from the age-adjusted analyses 
were not materially different: RR 1.58 (1.41–1.78) in women and 1.65 (1.46–1.87) in men. 
(Supplementary Figures 3 and 4). Restricting the analysis to studies that used higher quality 
research criteria to diagnose dementia had little effect on the summary estimates: 1.65 
(1.42–1.91) in women and 1.49 (1.19–1.87) in men. 
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Diabetes was associated with a significantly increased risk of vascular dementia in both 
women and men; the multiple-adjusted pooled RR (95% CI) was 2.34 (1.86-2.94) in women 
and 1.73 (1.61-1.85) in men (Figures 1 and 2). Between-study heterogeneity was moderate 
for women (I2=34%, p=0.14), and was absent for men (I2=0%, p=0.86). Excluding data from 
either of the large Asian cohorts had no discernible impact on the results (Supplementary 
Figure 2). The age-adjusted estimates were 2.23 (1.72-2.90) in women, and 2.02 (1.90–2.16) 
in men. The summary estimates from those studies that used the higher quality research 
criteria for the diagnosis of dementia did not differ appreciably from the multiple-adjusted 
estimates: 2.43 (1.67–3.54) and 1.86 (1.25–2.76). 
 
Individuals with diabetes also had 50% increased risk of developing non-vascular dementia 
compared with unaffected people: the multiple-adjusted pooled RR (95% CI) was 1.53 (1.35-
1.73) in women and 1.49 (1.31-1.69) in men (Figures 1 and 2). Between-study heterogeneity 
was low-moderate in both sexes (I2=30%, p=0.16 in women and 19%, p=0.27 in men). These 
estimates were largely unaffected after exclusion of data from the two largest studies 
(Supplementary Figure 2). The age-adjusted estimates were weaker in both women and 
men: 1.44 (1.26 -1.65) and 1.34 (1.05-1.70), respectively. Restricting to studies that used 
research criteria for the diagnosis of dementia did not materially affect the summary 
estimates: 1.47 (1.20–1.81) in women and 1.34 (0.99–1.80) in men. 
 
Diabetes conferred a significantly greater excess risk of developing dementia in women, but 
this was confined to vascular dementia (Figure 3). Women with diabetes had 19% (8-30%; p 
<0.001) greater excess risk of vascular dementia compared with men with diabetes, with no 
evidence of significant between-study heterogeneity (I
2
=0%; p =0.58). This effect remained 
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following exclusion of data from the Korean study (RRR 1.18: 1.07–1.30) and the Taiwanese 
study, although it was then no longer statistically significant: RRR 1.33 (0.94-1.88) 
(Supplementary Figure 23). In the age-adjusted analysis, there was no significant sex 
difference in the association between diabetes and vascular dementia (RRR 1.10 [0.84-1.45], 
p=0.49).; Supplementary Figure 6). For non-vascular dementia there was no evidence of a 
sex difference in the effect of diabetes from either the multiple-adjusted estimate (Figure 3) 
or the age-adjusted estimate (Supplementary Figure 4RRR 1.05 [0.81-1.36]). The results did 
not change appreciably after excluding data from the Taiwanese or Korean studies 
(Supplementary Figure 23). Restricting the analysis to those studies that used the research 
criteria for the diagnosis of dementia produced a similar pattern of results although the sex 
difference with vascular dementia was no longer statistically significant (RRR 1.24 [0.73-
2.11]).   
 
Given the substantial variation in background rates of dementia and its major subtypes 
across the studies we examined what impact such heterogeneity may have had on the RRR 
estimate through meta-regression analysis.. As shown in Supplementary Figure 5, Tthe 
overall estimate of the RRR was robust to between study differences in diabetes incident 
rates as there was no significant evidence that differences in background rates materially 
influenced the RRR estimate for either vascular dementia (p for heterogeneity =0.22) or non-
vascular dementia (p for heterogeneity =0.30).  
 
DISCUSSION 
This pooled analysis of 14 studies combined largely unpublished data from more than 2.3 
million individuals and information on more than 102,000 incident cases of dementia–more 
Formatted: Subscript
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than seven times the amount of information as in previous reviews of the same topic.4, 10, 11 
Our findings offer support for a role of diabetes in the etiology of dementia, although the 
magnitude of the relationship differs according to subtype Overall, diabetes was associated 
with about a 60% increased risk of all-cause dementia and 40% risk of non-vascular 
dementia in both women and men, independent of important confounders. For vascular 
dementia, the association was stronger with evidence of a stronger effect in women than in 
men. Compared with people with no diabetes, after adjusting for possible confounders, 
women with diabetes had 120% greater risk of developing vascular dementia compared 
with 70% greater risk in men, which equated to an 18% significantly greater excess risk in 
women with diabetes compared with similarly affected men. These results were largely 
robust to the exclusion of data from two large cohorts that together comprised 96% of all 
incident cases of dementia.
6, 12
 
 
The recorded excess relative risk of vascular dementia in women might be an artifact of the 
data driven by higher absolute rates for incident dementia in men than in women in the 
background population. If this were true, then the relative effect of diabetes on incident 
dementia would be greater in women than in men in populations in which the absolute 
incident rate is higher in men than in women, but should converge when the rates are 
similar between the sexes. However, our present findings show evidence to the contrary, 
with a trend towards higher incident rate ratios (indicating a greater excess risk in women 
than men) in studies in which the background incident rates for dementia were higher in 
women than in men. 
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Previous reviews of the association between diabetes and risk of dementia reported slightly 
larger estimates but still compatible to those presented here.4, 10, 11 Moreover, as these 
reviews were reliant on published data they were largely unable to examine the effect of 
diabetes on dementia subtypes, the impact of confounding, or to perform sex-specific 
comparisons. In contrast, by sourcing previously unpublished study-level estimates, we 
were largely able to overcome these limitations. Moreover, by standardizing the level of 
adjustment for other major vascular risk factors across studies (as far as possible) we not 
only lessened the possible effect of residual confounding on study estimates, but we could 
also examine whether adjustment had a similar effect on the age-adjusted estimates for 
women and men. Our findings indicated that adjustment for other vascular risk factors on 
the association between diabetes and risk of vascular dementia had opposing effects in 
women and men: in women, adjustment tended to strengthen the association (by roughly 
7%) whereas in men the association was somewhat weakened (by 14%) – which would 
explain the lack of an observed sex difference in the risk of diabetes for vascular dementia in 
the age-adjusted estimate. 
 
While several processes are thought to promote the onset of dementia in individuals with 
diabetes, the biological basis of this relationship is still uncertain. Findings from a recent 
study that examined the genetic susceptibility to type 2 diabetes and risk of late-onset AD 
have shown that genotype risk scores for diabetes were not associated with increased risk 
of late-onset AD.26 Therefore, even though we attempted to control for confounding, it is 
probable that the observed association between diabetes and non-vascular dementia is 
non-causal and possibly driven by other disease processes or known (and unknown) risk 
factors that are common to both diabetes and non-vascular dementia. But, both the size of 
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the association, and the fact that diabetes is a known risk factor for micro- and 
macrovascular complications–including CHD and stroke, would suggest that the relationship 
between diabetes and vascular dementia is robust and not solely driven by confounding.  
 
Studies in support of a biological relationship between diabetes and vascular and non-
vascular dementia, suggest a multifactorial pathogenesis involving insulin metabolism, 
hyperglycemic toxicity, chronic inflammatory processes and vascular changes.27, 28 Insulin 
resistance is thought to promote atherosclerosis, change cerebral energy metabolism, and 
to lead to vascular-related cognitive impairment and dementia.27 Oxidative stress due to 
chronic hyperglycaemia can also lead to vascular changes in the nervous system, and an 
accumulation of advanced glycation end-products that are found in AD.
28
 Conversely, severe 
hypoglycaemia, which in most cases is driven by insulin or sulfonylurea treatment of 
diabetes, is associated with cognitive impairment by precipitating neuronal death and 
increased production of coagulation factors.27 Type 2 diabetes is also associated with an 
increased expression of interleukin-6 (IL-6) in the central nervous system, causing 
inflammation of the brain and in conjunction with oxidative stress is implicated in the 
pathogenesis of AD.
27
 Two prospective neuropathological cohort studies suggested that 
diabetes may lower the threshold for the amount of amyloid required for development of 
AD by inducing adverse microvascular changes–small vessel infarcts–in the brain.28,29 There 
is now growing evidence to suggest that dementia subtypes are more heterogeneous 
pathologically than previously thought, and underlying vascular changes play a role in both 
vascular and non-vascular dementia.
3  
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The present analyses provide further support for the hypothesis that the adverse 
consequences of diabetes on vascular risk are stronger in women than in men.7-9 While a sex 
disparity in the management and treatment of diabetes, most often to the detriment of 
women, may be involved, accruing evidence suggests that real biological differences 
between women and men underpin the excess risk of diabetes-related vascular risk in 
women.  For example, exposure to endogenous estradiol in women may also play a role; a 
recent study among post-menopausal women found that higher levels of endogenous 
estradiol, especially in women with diabetes, conferred a greater risk of dementia.30 There is 
also some evidence from autopsy studies to suggest that the greater diabetes-related excess 
risk of vascular dementia observed in women may be mediated by greater neurological 
microvascular damage: based on neuropathological assessment the Adult Changes in 
Thought Study reported two patterns of cerebral injury associated with dementia in 
individuals with and without diabetes. In those without diabetes, dementia was associated 
with higher amyloid-B peptide while in individuals with diabetes, dementia was 
characterised by greater microvascular infarcts and neuroinflammation 31. However, 
whether the latter was more pronounced in women than in men was not examined and 
requires further investigation by future studies that are adequately powered to detect sex 
differences.  
 
Limitations of our study include the differences across studies in study design and duration, 
endpoint definition, and ascertainment of diabetes (which was either measured or based on 
self-report depending on the study). We were also unable to include data from 14 eligible 
cohorts with 2,300 incident cases of dementia. However, given that the current analyses are 
based on more than 100,000 incident cases it is unlikely that their omission had a profound 
Page 16 of 69
CONFIDENTIAL-For Peer Review Only
Diabetes Care
17 
 
impact on the results. It should be noted however, that more than 96% of the cases were 
derived from two large studies; reassuringly however, exclusion of either study did not 
materially alter the pattern of the results (although in some instances the associations were 
not statistically significant). It should be noted however, that the heterogeneity in the 
method of diagnosis of dementia and its subtypes is a significant (and unquantifiable) 
limitation of this analysis. For example, ascertainment of dementia from the two large Asian 
cohorts was reliant on diagnoses obtained from administrative databases that may be 
particularly susceptible to detection bias or case reporting,  (supplementary reference 16) 32 
whereas in other, much smaller studies, a diagnosis of dementia was based on clinical 
examination by two or more clinicians 25. We also did not examine the association between 
duration of diabetes or glycaemic control and the risk for dementia, nor did we evaluate the 
association between diabetes and cognitive functioning. The diagnosis of vascular dementia 
in epidemiological studies, and its overlap with AD and other forms of dementia, without 
neuropathological validation is also a significant limitation and may have overestimated the 
impact of diabetes for dementia subtypes. While we used accepted criteria to distinguish 
between Alzheimer’s disease and vascular dementia, there is increasing recognition that 
dementia has a mixed pathophysiology (Supplementary references 17,18)gy33
,34
.  At the 
present, no standardised thresholds by which to categorise mixed dementia exist, and was 
not examined within the individual studies, hence, we were unable to examine sex 
differences in the diabetes-related risk of mixed dementia.  Misclassification of dementia 
status – which may have occurred differentially in women and men – will have introduced 
bias, the extent (and direction) of which remains unknown. We also did not have 
information on duration of diabetes status and level of glycemic control either of which may 
Formatted: Highlight
Formatted: Highlight
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have significantly interacted with risk of dementia (either to a similar or different extent in 
women and men). 
 
Future prospective studies, with extensive phenotypic and genetic data on risk factors 
common to both diabetes and subtypes of dementia, are needed to examine whether these 
relationships are causal. Moreover, our finding of a greater diabetes-related risk of vascular 
dementia in women than in men contributes to the growing evidence base that diabetes 
confers a proportionally greater vascular hazard in women than in men. 
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FIGURE LEGEND 
 
Figure 1: Multiple-adjusted relative risk for any dementia, vascular dementia and non-
vascular dementia in women, comparing individuals with diabetes to those without 
diabetes. Horizontal bars represent 95% confidence intervals. RR=relative risk; 
CI=confidence interval. 
 
Figure 2: Multiple-adjusted relative risk for any dementia, vascular dementia and non-
vascular dementia in men, comparing individuals with diabetes to those without diabetes.  
Horizontal bars represent 95% confidence intervals. RR=relative risk; CI=confidence interval. 
 
Figure 3: Multiple-adjusted women to men ratio of relative risks for any dementia, 
vascular dementia and non-vascular dementia, comparing individuals with diabetes to 
those without diabetes.  
Horizontal bars represent 95% confidence intervals. RRR= women to men ratio of relative 
risk; CI=confidence interval. 
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Table 1: Characteristics of included studies 
Cohort Country Baseline 
study 
(years) 
Mean FU 
(years) 
Age 
range 
(years)  
N      
(% w) 
N 
diabetes 
(% w) 
N 
dementia  
(% w) 
N VaD (% 
w) 
N non-
VaD  (% 
w) 
Ascertainment 
of diabetes 
Ascertainment 
of dementia 
Maximum 
adjustment 
available 
ACT Study
18
 US 1994-96 7 65+  2067 (59)  232 (52)  524 (62)  67 (61)  457 (62)  Measured Cognitive 
Abilities 
Screening 
Instrument, 
DSM, 
NINCDS/ADRDA 
Age, sbp, 
smoking, bmi  
ARIC
15
 US 1990-92 14 46-70 11151 
(57)  
1445 (55)  203 (57)  NA NA Measured or 
SR 
ICD-9 codes  Age, race, sbp, 
smoking, bmi, tc 
CCMS
20
 US 1995 5 65+ 3260 (58)  343 (53)  141 (71)  37 (65)  104 (73)  SR DSM, 
NINCDS/ADRDA,  
NINDS-AIREN 
Age, 
hypertension, 
bmi, high 
cholesterol 
English and 
Scottish 
Health 
surveys
16
 
UK 1998-08 8 16-102 154844 
(52)  
12267 
(48)  
1242 (54)  NA NA SR ICD-9, ICD-10 
codes  
Age, sbp, 
smoking, bmi, tc 
Framingham 
Study
14
 
US 1976-78 13 NR 2609 (56)  363 (43)  234 (61)  51 (61)  183 (61)  Measured DSM, 
NINCDS/ADRDA, 
NINDS-AIREN 
Age, sbp, 
smoking, bmi, tc 
Hisayama 
Study
23
 
Japan 1985-88 15 60+ 1017 (57)  150 (55)  232 (66)  65 (51)  167 (72)  Measured DSM, 
NINCDS/ADRDA,  
NINDS-AIREN 
Age, sbp, 
smoking, bmi, tc 
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Cohort Country Baseline 
study 
(years) 
Mean FU 
(years) 
Age 
range 
(years)  
N      
(% w) 
N 
diabetes 
(% w) 
N 
dementia  
(% w) 
N VaD 
 (% w) 
N non-
VaD  (% 
w) 
Ascertainment 
of diabetes 
Ascertainment 
of dementia 
Maximum 
adjustment 
available 
Kame Project
17
 US 1992-
1994 
6 65+ 1709 (55)  290 (44)  140 (59)  45 (58)  112 (63)  SR DSM, 
NINCDS/ADRDA, 
NINDS-AIREN 
Age, sbp, 
smoking, bmi 
Kungsholmen 
Project
25
 
Sweden 1987-89 9 75+ 1301 (75)  104 (75)  350 (81)  49 (71)  301 (83)  SR DSM, 
NINCDS/ADRDA,  
NINDS-AIREN 
Age, sbp, 
smoking, bmi  
MHAS
22
 Mexico 2001-03 3 60 + 5398 (54) 749 (61) 306 (60) 54 (63) 230 (61) SR CCCE, IQCODE Age, 
hypertension, 
smoking, obesity 
NHI, Taiwan
12
 Taiwan 2000-08 9 NR 1229747 
(52)  
614876 
(52)  
95087 
(57)  
8300 (52)  86757 
(57)  
Measured ICD-9 codes  Age, insurance 
premium, region, 
urbanization 
cbvd, cvd, 
hypertension, 
hyperlipidemia 
NHIC, Korea
6
 Korea 1992-95 14 40-95 848505 
(42)  
51611 
(35)  
2914 (55)  516 (47)  1669 (57)  Measured DSM and 
medical 
examination 
Age, alcohol 
Norwegian 
Counties 
Study
24
 
Norway 1974-78 35 35-50 46231 
(51)  
613 (34)  460 (53)  NA NA Measured or 
SR 
ICD-9 codes  Age, sbp, 
smoking, bmi, tc 
OCTO-Twin 
Study
19, 21
 
Sweden 1991-99 9 80+ 702 (67)  122 (67)  225 (70)  57 (58)  163 (73)  Measured DSM, 
NINCDS/ADRDA,  
NINDS-AIREN 
Age, sbp, 
smoking, bmi, tc 
SALSA Study
21
 US 1998-99 10 60+ 1789 (58)  797 (56)  116 (66)  12 (50)  90 (71)  Measured or 
SR 
DSM, 
NINCDS/ADRDA,  
Age, sbp, 
smoking, bmi, tc 
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Study abbreviations: %w; percent women; ACT, Adult Changes in Thought; ARIC, Atherosclerosis Risk in Communities Study; CCMS, Cache 
County Memory Study; MHAS, Mexican Health and Aging Study; NHI, National Health Insurance; NHIC, National Health Insurance Corporation; 
OCTO, Origins of Variance in the Old-Old; SALSA, Sacramento Area Latino Study on Aging. 
Abbreviations: BMI, body mass index; CCCE, Cross-Cultural Cognitive Examination; cbvd, cerebrovascular disease; cvd, cardiovascular disease; 
DSM, Diagnostic and Statistical Manual of Mental Disorders; ICD, International Classification of Disease; IQCODE Informant Questionnaire on 
COgnitive Decline in the Elderly; NA, not available; NINCDS/ADRDA, National Institute of Neurological and Communicative Disorders and Stroke 
and the Alzheimer's Disease and Related Disorders Association criteria; NINDS-AIREN, National Institute of Neurological Disorders and Stroke 
and Association Internationale pour la Recherché et l'Enseignement en Neurosciences criteria; sbp, systolic blood pressure; tc, total 
cholesterol, VaD, Vascular Dementia; SR, self-report diabetes; UK, United Kingdom; US, United States of America 
NINDS-AIREN 
Page 29 of 69
CONFIDENTIAL-For Peer Review Only
Diabetes Care
1 
 
Type 2 diabetes as a risk factor for dementia in women compared with men: a pooled 
analysis of 2.3 million people comprising more than 100,000 cases of dementia 
 
Short running title: Sex differences in diabetes-related risk of dementia 
 
Saion Chatterjee MBBS *a,b, Sanne A.E. Peters PhD *c, Mark Woodward PhD c,d,e , Silvia Mejia 
Arango PhD f, G. David Batty DSc g,h,i, Nigel Beckett MB ChB j, Alexa Beiser PhD k, Amy R. 
Borenstein PhD 
l
, Paul K Crane MD MPH 
m
, Mary Haan DrPH 
n
, Linda B. Hassing PhD 
o
, 
Kathleen M. Hayden PhD p, Yutaka Kiyohara MD  PhD q, Eric B Larson MD, MPH r, Chung-Yi Li 
PhD s, Toshiharu Ninomiya MD PhD q, Tomoyuki Ohara MD PhD q, Ruth Peters PhD j, Tom C 
Russ PhD MRCPsych h,I,t,u, Sudha Seshadri MD v, Bjørn H. Strand PhD w, Rod Walker MS r, 
Weili Xu PhD x,y,  Rachel R. Huxley DPhil a 
 
*Joint first authors 
a School of Public Health, Curtin University, Perth Australia; b Alfred Health, Melbourne, 
Australia; 
c 
The George Institute for Global Health, Nuffield Department of Population 
Health, University of Oxford, UK; d The George Institute for Global Health, University of 
Sydney, Sydney, Australia; e Department of Epidemiology, Johns Hopkins University, 
Baltimore, MD, USA; 
f 
Department of Population Studies , El Colegio de la Frontera Norte, 
Tijuana, Baja California, México; g Department of Epidemiology and Public Health, University 
College, London UK; h Centre for Cognitive Ageing and Cognitive Epidemiology, University of 
Edinburgh, Edinburgh, UK; 
I 
Alzheimer Scotland Dementia Research Centre, University of 
Edinburgh, Edinburgh, UK; j Care of the Elderly Imperial College Faculty of Medicine, London, 
UK; k Department of Biostatistics, Boston University School of Public Health, Boston, MA, 
Page 30 of 69
CONFIDENTIAL-For Peer Review Only
Diabetes Care
2 
 
USA; l Department of Epidemiology and Biostatistics, College of Public Health, University of 
South Florida, Tampa, Florida, USA; 
m 
Department of Medicine, University of Washington, 
Seattle, USA; n Department of Epidemiology and Biostatistics, University of California, San 
Francisco, San Francisco, USA; o Department of Psychology, Gothenburg University, 
Gothenburg, Sweden; Department of Social Sciences and Health Policy, Wake Forest School 
of Medicine, Winston-Salem, NC, USA; q Department of Environmental Medicine, Graduate 
School of Medical Sciences, Kyushu University, Fukuoka, Japan; r Group Health Research 
Institute, Seattle, USA; 
s 
Department and Graduate Institute of Public Health, College of 
Medicine, National Cheng Kung University, Tainan, Taiwan; t Scottish Dementia Clinical 
Research Network, NHS Scotland, Edinburgh, UK; u Division of Psychiatry, University of 
Edinburgh, Edinburgh, UK; v Department of Neurology, Boston University School of 
Medicine, Boston, MA, USA; w Norwegian Institute of Public Health, Oslo, Norway; x Aging 
Research Centre, Department of Neurobiology, Care Sciences and Society, Karolinska 
Institute and Stockholm University, Stockholm, Sweden; y School of Public Health, Tianjin 
Medical University, Tianjin, China. 
 
Word count (abstract) = 250 
Word count (main text) = 3787 
 
Correspondence 
Professor Rachel Huxley 
School of Public Health,  
Curtin University, Perth,  
Western Australia, 6845 
Page 31 of 69
CONFIDENTIAL-For Peer Review Only
Diabetes Care
3 
 
Email: rachel.huxley@ curtin.edu.au 
 Tel | +61 8 9266 9478   Fax | +61 8 9266 2958 
  
Page 32 of 69
CONFIDENTIAL-For Peer Review Only
Diabetes Care
4 
 
ABSTRACT 
Objective: Type 2 diabetes confers a greater excess risk of cardiovascular disease in women 
than in men. Diabetes is also a risk factor for dementia but whether the association is similar 
in women and men remains unknown. We performed a meta-analysis of unpublished data 
to estimate the sex-specific relationship between diabetes with incident dementia. 
 
Research Design and Methods: A systematic search identified studies published prior to 
November 2014 that had reported on the prospective association between diabetes and 
dementia. Study authors contributed unpublished sex-specific relative risks (RR) and 95% 
confidence intervals (95% CI) on the association between diabetes and all dementia and its 
subtypes. Sex-specific RRs and the women-to-men ratio of RRs (RRRs) were pooled using 
random-effects meta-analyses. 
 
Results: Study-level data from 14 studies, 2,310,330 individuals and 102 174 dementia cases 
were included. In multiple-adjusted analyses, diabetes was associated with 60% increased 
risk of any dementia in both sexes: pooled RR (95% CI) 1.62 (1.45-1.80) in women, and 1.58 
(1.38-1.81) in men, respectively.  The diabetes-associated RRs (95% CI) for vascular 
dementia were 2.34 (1.86-2.94) in women and 1.73 (1.61-1.85) in men, and for non-vascular 
dementia were 1.53 (1.35-1.73) in women and 1.49 (1.31-1.69) in men. Overall, women with 
diabetes had 19% greater risk of developing vascular dementia than men: multiple-adjusted 
RRR 1.19 (1.08-1.30) p<0.001.  
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Conclusions: Individuals with type 2 diabetes are at approximately 60% greater risk of 
developing dementia compared with those without diabetes. For vascular, but not for non-
vascular dementia, the additional risk is greater in women.  
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Dementia is a multi-faceted syndrome that lays claim to a growing burden of global disease: 
the most recent estimates suggest that there are approximately 44 million affected 
individuals worldwide and a further 7.7 million new cases annually.1, 2 Underpinned by a 
shifting demographic and associated epidemiological profile worldwide, the prevalence of 
dementia is forecast to nearly double by 2030, and to triple by 2050, and is set to create a 
significant economic, social and public health burden particularly in resource-poor 
countries.1, 2  
 
Non-vascular dementia, which mainly constitutes Alzheimer's disease (AD), and vascular 
dementia are the two most common forms of dementia, accounting for about 70% (25 
million) and 20% (7 million) of all dementia cases, respectively.2 Lifestyle risk factors 
including type 2 diabetes, cigarette smoking, and obesity are associated with an increased 
risk of developing both vascular dementia and non-vascular dementia in later life.3 For 
example, a review that included information on approximately 15,000 cases of dementia, 
found that, compared to non-affected individuals, those with diabetes had roughly 70% 
greater risk of developing dementia.
4
  
 
While of value, this review has some important limitations4: over 73% of dementia cases 
were derived from two large Asian cohorts,
5, 6
 and the influence of these studies on the 
overall summary estimates was not examined. Moreover, information on dementia 
subtypes was not universally available, including the single study that provided information 
on more than 50% of all dementia cases.
5
 Finally, as the analyses were not sex-specific it 
was not possible to determine whether the magnitude of the association between diabetes 
and incident dementia and its main subtypes differed in women and men. This is of interest 
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given the substantial amount of evidence suggesting that diabetes confers a significantly 
greater additional vascular hazard in women compared with men which potentially has 
ramifications for the clinical management of diabetes and vascular disease in women.7-9  
 
To overcome the substantial methodological limitations of past reviews, we requested 
individual study investigators to contribute unpublished results to a pooled analysis. In line 
with the current evidence base which suggests that diabetes poses more of a vascular 
hazard in women compared with men, our hypothesis was that diabetes confers a greater 
excess risk of vascular dementia in women than in men but that the impact of diabetes on 
risk of non-vascular dementia is similar between the sexes.   
 
RESEARCH DESIGN AND METHODS 
Search strategy and selection criteria 
We used PubMed MEDLINE (www.ncbi.nlm.nih.gov) and OVID MEDLINE for the period from 
January, 2011 to November, 2014 to identify studies that had reported on the association 
between diabetes and dementia in men and women from a general population. The search 
strategy combined the following text terms and MeSH: 'dementia', 'vascular dementia', 
'delirium', 'cognitive disorders', 'amnestic disorders', 'frontotemporal dementia', multi-
infarct dementia', 'Alzheimer disease', Lewy body', 'type 2 diabetes mellitus', 'diabetes 
mellitus', 'DM', 'diabetes complications', 'blood glucose', 'impaired glucose tolerance', 
'glycosylated hemoglobin', and 'prediabetes'. Studies prior to 2011 were identified from 
previous systematic reviews.
4, 10, 11
 Data from randomized trials were excluded due to the 
non-generalizable nature of trials to the general population. Two authors (SAEP and SC) 
conducted the literature search. Uncertainties regarding the identification of studies were 
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discussed and resolved by mutual consent. Since most studies did not publish estimates of 
relative risk separately for men and women or for dementia subtypes, and varied by which 
factors were included in adjusted models, we contacted authors of all the selected studies 
and asked them to provide additional results adjusted, where possible, for the same set of 
confounders: blood pressure, cigarette smoking, body mass index and total cholesterol. On 
a specifically designed form, contributing authors provided summary results for the age- and 
multiple-adjusted relative risks (RRs) and 95% confidence intervals (CIs) for any dementia, 
and if available, for vascular dementia and non-vascular dementia segregated by sex.  
 
Data extraction and statistical analysis 
The primary endpoints were incident all-cause dementia, vascular dementia, and non-
vascular dementia (as defined by the study investigators: see Supplementary Table 1). The 
primary metrics were the pooled multiple-adjusted RRs for dementia associated with 
diabetes and the women-to-men ratio of the RRs (RRR). Covariates that were included in the 
multiple-adjusted model were reported differently between studies and are shown in Table 
1. Age-adjusted estimates were used in a secondary analysis. From each study, we obtained 
the previously unpublished sex-specific RRs with accompanying 95% CIs for individuals with 
versus without diabetes. We also requested information on person-years of follow-up to 
calculate sex-specific incidence rates in individuals with and without diabetes. We log-
transformed these RRs and pooled them across studies using random effects meta-analysis 
with inverse variance weighting, and then exponentiated these values to obtain the pooled 
RR separately for women and men. We used similar methods to pool women-to-men ratio 
of RRs. For each study, we obtained the standard error of the log RRR by taking the square 
root of the sum of the variance of the two sex-specific log RRs. We used the I² statistic to 
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estimate the percentage of variability across studies due to between-study heterogeneity. In 
sensitivity analyses, we excluded estimates from two large cohort studies from Taiwan and 
Korea which had a large influence on the summary estimates.6, 12 We also examined 
whether restricting the analysis to those studies that used higher quality research criteria 
for dementia diagnosis (e.g. the Cross cultural Cognitive Examination, National Institute of 
Neurological and Communicative Disorders and Stroke, Alzheimer’s Disease and Related 
Disorders Association criteria) affected the main results.  We explored whether the 
background rate of dementia in the study population influenced the sex-specific 
associations by meta-regression analyses of the log RRR versus the difference in incidence 
rate between women with and without diabetes minus the equivalent estimate in men (i.e. 
the difference of the difference). We assessed the methodological quality of the studies 
using the Newcastle-Ottawa Scale (Supplementary methods).13 All analyses were performed 
using Stata version 12.0. 
 
RESULTS 
The systematic search identified 1495 unique articles that were subsequently examined on 
title and abstract (Supplementary Figure 1). Overall, 1425 articles were excluded for one or 
more reasons including lack of primary data, single-sex population, animal study, non-
prospective study design, and randomized trial of a high-risk population. Of the remaining 
articles, 70 articles qualified for full-text evaluation. Of these, 28 studies had relevant data 
on the relationship between diabetes and risk of dementia and the authors were contacted 
and asked to contribute additional estimates to those in the published reports. Authors 
from 13 studies (response 48%) contributed unpublished summary data,12, 14-25 and for one 
study we extracted the necessary data from its published report.6 The 14 non-contributing 
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studies comprised 30,900 individuals and 2,300 cases of dementia (Supplementary 
references) and the baseline characteristics are described in Table 1. Overall, data were 
available on 2,310,330 individuals (48% women) and 102,174 incident cases of dementia, 
including 9,253 cases of vascular dementia (52% women) and 90,233 cases of non-vascular 
dementia (58% women). Three cohorts were from Asia (90% of the individuals),
6, 12, 23
 four 
from Europe (9%),16, 19, 24, 25 and seven from the Americas (1%).14, 15, 17, 18, 20-22 The mean age 
of study participants ranged from 43 to 83 years, and the mean study duration ranged from 
two to 35 years across studies. The included studies were generally of good to very good 
quality (Supplementary Table 1). There was variation in the incidence rates for dementia 
between populations (Supplementary Table 2). 
 
Compared with not having diabetes, diabetes was significantly associated with 
approximately 60% increased risk of any dementia in both sexes; the multiple-adjusted 
pooled RR (95% CI) for any dementia associated with diabetes was 1.68 (1.64-1.71) in 
women and 1.61 (1.42-1.83) in men (Figures 1 and 2). There was moderate heterogeneity 
between studies in both women (I
2
=40%; p=0.065) and men (I
2
=48%, p=0.048). The size of 
the associations in women and men remained robust after excluding data, in turn, from the 
two large Asian cohorts (Supplementary Figure 2). Results from the age-adjusted analyses 
were not materially different: RR 1.58 (1.41–1.78) in women and 1.65 (1.46–1.87) in men. 
Restricting the analysis to studies that used higher quality research criteria to diagnose 
dementia had little effect on the summary estimates: 1.65 (1.42–1.91) in women and 1.49 
(1.19–1.87) in men. 
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Diabetes was associated with a significantly increased risk of vascular dementia in both 
women and men; the multiple-adjusted pooled RR (95% CI) was 2.34 (1.86-2.94) in women 
and 1.73 (1.61-1.85) in men (Figures 1 and 2). Between-study heterogeneity was moderate 
for women (I2=34%, p=0.14), and was absent for men (I2=0%, p=0.86). Excluding data from 
either of the large Asian cohorts had no discernible impact on the results (Supplementary 
Figure 2). The age-adjusted estimates were 2.23 (1.72-2.90) in women, and 2.02 (1.90–2.16) 
in men. The summary estimates from those studies that used the higher quality research 
criteria for the diagnosis of dementia did not differ appreciably from the multiple-adjusted 
estimates: 2.43 (1.67–3.54) and 1.86 (1.25–2.76). 
 
Individuals with diabetes also had 50% increased risk of developing non-vascular dementia 
compared with unaffected people: the multiple-adjusted pooled RR (95% CI) was 1.53 (1.35-
1.73) in women and 1.49 (1.31-1.69) in men (Figures 1 and 2). Between-study heterogeneity 
was low-moderate in both sexes (I2=30%, p=0.16 in women and 19%, p=0.27 in men). These 
estimates were largely unaffected after exclusion of data from the two largest studies 
(Supplementary Figure 2). The age-adjusted estimates were weaker in both women and 
men: 1.44 (1.26 -1.65) and 1.34 (1.05-1.70), respectively. Restricting to studies that used 
research criteria for the diagnosis of dementia did not materially affect the summary 
estimates: 1.47 (1.20–1.81) in women and 1.34 (0.99–1.80) in men. 
 
Diabetes conferred a significantly greater excess risk of developing dementia in women, but 
this was confined to vascular dementia (Figure 3). Women with diabetes had 19% (8-30%; p 
<0.001) greater excess risk of vascular dementia compared with men with diabetes, with no 
evidence of significant between-study heterogeneity (I2=0%; p =0.58). This effect remained 
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following exclusion of data from the Korean study (RRR 1.18: 1.07–1.30) and the Taiwanese 
study, although it was then no longer statistically significant: RRR 1.33 (0.94-1.88) 
(Supplementary Figure 2). In the age-adjusted analysis, there was no significant sex 
difference in the association between diabetes and vascular dementia (RRR 1.10 [0.84-1.45], 
p=0.49).For non-vascular dementia there was no evidence of a sex difference in the effect of 
diabetes from either the multiple-adjusted estimate (Figure 3) or the age-adjusted estimate 
(RRR 1.05 [0.81-1.36]). The results did not change appreciably after excluding data from the 
Taiwanese or Korean studies (Supplementary Figure 2). Restricting the analysis to those 
studies that used the research criteria for the diagnosis of dementia produced a similar 
pattern of results although the sex difference with vascular dementia was no longer 
statistically significant (RRR 1.24 [0.73-2.11]).   
 
Given the substantial variation in background rates of dementia and its major subtypes 
across the studies we examined what impact such heterogeneity may have had on the RRR 
estimate through meta-regression analysis. The overall estimate of the RRR was robust to 
between study differences in diabetes incident rates as there was no significant evidence 
that differences in background rates materially influenced the RRR estimate for either 
vascular dementia (p for heterogeneity = 0.22) or non-vascular dementia (p for heterogeneity = 0.30) 
 
DISCUSSION 
This pooled analysis of 14 studies combined largely unpublished data from more than 2.3 
million individuals and information on more than 102,000 incident cases of dementia–more 
than seven times the amount of information as in previous reviews of the same topic.4, 10, 11 
Our findings offer support for a role of diabetes in the etiology of dementia, although the 
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magnitude of the relationship differs according to subtype Overall, diabetes was associated 
with about a 60% increased risk of all-cause dementia and 40% risk of non-vascular 
dementia in both women and men, independent of important confounders. For vascular 
dementia, the association was stronger with evidence of a stronger effect in women than in 
men. Compared with people with no diabetes, after adjusting for possible confounders, 
women with diabetes had 120% greater risk of developing vascular dementia compared 
with 70% greater risk in men, which equated to an 18% significantly greater excess risk in 
women with diabetes compared with similarly affected men. These results were largely 
robust to the exclusion of data from two large cohorts that together comprised 96% of all 
incident cases of dementia.6, 12 
 
The recorded excess relative risk of vascular dementia in women might be an artifact of the 
data driven by higher absolute rates for incident dementia in men than in women in the 
background population. If this were true, then the relative effect of diabetes on incident 
dementia would be greater in women than in men in populations in which the absolute 
incident rate is higher in men than in women, but should converge when the rates are 
similar between the sexes. However, our present findings show evidence to the contrary, 
with a trend towards higher incident rate ratios (indicating a greater excess risk in women 
than men) in studies in which the background incident rates for dementia were higher in 
women than in men. 
 
Previous reviews of the association between diabetes and risk of dementia reported slightly 
larger estimates but still compatible to those presented here.4, 10, 11 Moreover, as these 
reviews were reliant on published data they were largely unable to examine the effect of 
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diabetes on dementia subtypes, the impact of confounding, or to perform sex-specific 
comparisons. In contrast, by sourcing previously unpublished study-level estimates, we 
were largely able to overcome these limitations. Moreover, by standardizing the level of 
adjustment for other major vascular risk factors across studies (as far as possible) we not 
only lessened the possible effect of residual confounding on study estimates, but we could 
also examine whether adjustment had a similar effect on the age-adjusted estimates for 
women and men. Our findings indicated that adjustment for other vascular risk factors on 
the association between diabetes and risk of vascular dementia had opposing effects in 
women and men: in women, adjustment tended to strengthen the association (by roughly 
7%) whereas in men the association was somewhat weakened (by 14%) – which would 
explain the lack of an observed sex difference in the risk of diabetes for vascular dementia in 
the age-adjusted estimate. 
 
While several processes are thought to promote the onset of dementia in individuals with 
diabetes, the biological basis of this relationship is still uncertain. Findings from a recent 
study that examined the genetic susceptibility to type 2 diabetes and risk of late-onset AD 
have shown that genotype risk scores for diabetes were not associated with increased risk 
of late-onset AD.26 Therefore, even though we attempted to control for confounding, it is 
probable that the observed association between diabetes and non-vascular dementia is 
non-causal and possibly driven by other disease processes or known (and unknown) risk 
factors that are common to both diabetes and non-vascular dementia. But, both the size of 
the association, and the fact that diabetes is a known risk factor for micro- and 
macrovascular complications–including CHD and stroke, would suggest that the relationship 
between diabetes and vascular dementia is robust and not solely driven by confounding.  
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Studies in support of a biological relationship between diabetes and vascular and non-
vascular dementia, suggest a multifactorial pathogenesis involving insulin metabolism, 
hyperglycemic toxicity, chronic inflammatory processes and vascular changes.27, 28 Insulin 
resistance is thought to promote atherosclerosis, change cerebral energy metabolism, and 
to lead to vascular-related cognitive impairment and dementia.27 Oxidative stress due to 
chronic hyperglycemia can also lead to vascular changes in the nervous system, and an 
accumulation of advanced glycation end-products that are found in AD.
28
 Conversely, severe 
hypoglycaemia, which in most cases is driven by insulin or sulfonylurea treatment of 
diabetes, is associated with cognitive impairment by precipitating neuronal death and 
increased production of coagulation factors.27 Type 2 diabetes is also associated with an 
increased expression of interleukin-6 (IL-6) in the central nervous system, causing 
inflammation of the brain and in conjunction with oxidative stress is implicated in the 
pathogenesis of AD.27 Two prospective neuropathological cohort studies suggested that 
diabetes may lower the threshold for the amount of amyloid required for development of 
AD by inducing adverse microvascular changes–small vessel infarcts–in the brain.
28,29
 There 
is now growing evidence to suggest that dementia subtypes are more heterogeneous 
pathologically than previously thought, and underlying vascular changes play a role in both 
vascular and non-vascular dementia.
3  
 
 
The present analyses provide further support for the hypothesis that the adverse 
consequences of diabetes on vascular risk are stronger in women than in men.
7-9
 While a sex 
disparity in the management and treatment of diabetes, most often to the detriment of 
women, may be involved, accruing evidence suggests that real biological differences 
Page 44 of 69
CONFIDENTIAL-For Peer Review Only
Diabetes Care
16 
 
between women and men underpin the excess risk of diabetes-related vascular risk in 
women.  For example, exposure to endogenous estradiol in women may also play a role; a 
recent study among post-menopausal women found that higher levels of endogenous 
estradiol, especially in women with diabetes, conferred a greater risk of dementia.30 There is 
also some evidence from autopsy studies to suggest that the greater diabetes-related excess 
risk of vascular dementia observed in women may be mediated by greater neurological 
microvascular damage: based on neuropathological assessment the Adult Changes in 
Thought Study reported two patterns of cerebral injury associated with dementia in 
individuals with and without diabetes. In those without diabetes, dementia was associated 
with higher amyloid-B peptide while in individuals with diabetes, dementia was 
characterised by greater microvascular infarcts and neuroinflammation (supplementary 
reference 15) 31. However, whether the latter was more pronounced in women than in men 
was not examined and requires further investigation by future studies that are adequately 
powered to detect sex differences.  
 
Limitations of our study include the differences across studies in study design and duration, 
endpoint definition, and ascertainment of diabetes (which was either measured or based on 
self-report depending on the study). We were also unable to include data from 14 eligible 
cohorts with 2,300 incident cases of dementia. However, given that the current analyses are 
based on more than 100,000 incident cases it is unlikely that their omission had a profound 
impact on the results. It should be noted however, that more than 96% of the cases were 
derived from two large studies; reassuringly however, exclusion of either study did not 
materially alter the pattern of the results (although in some instances the associations were 
not statistically significant). It should be noted however, that the heterogeneity in the 
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method of diagnosis of dementia and its subtypes is a significant (and unquantifiable) 
limitation of this analysis. For example, ascertainment of dementia from the two large Asian 
cohorts was reliant on diagnoses obtained from administrative databases that may be 
particularly susceptible to detection bias or case reporting, (supplementary reference 16) 
whereas in other, much smaller studies, a diagnosis of dementia was based on clinical 
examination by two or more clinicians 25. We also did not examine the association between 
duration of diabetes or glycaemic control and the risk for dementia, nor did we evaluate the 
association between diabetes and cognitive functioning. The diagnosis of vascular dementia 
in epidemiological studies, and its overlap with AD and other forms of dementia, without 
neuropathological validation is also a significant limitation and may have overestimated the 
impact of diabetes for dementia subtypes. While we used accepted criteria to distinguish 
between Alzheimer’s disease and vascular dementia, there is increasing recognition that 
dementia has a mixed pathophysiology (supplementary references 17, 18).  At the present, 
no standardised thresholds by which to categorise mixed dementia exist, and was not 
examined within the individual studies, hence, we were unable to examine sex differences 
in the diabetes-related risk of mixed dementia.  Misclassification of dementia status – which 
may have occurred differentially in women and men – will have introduced bias, the extent 
(and direction) of which remains unknown. We also did not have information on duration of 
diabetes status and level of glycemic control either of which may have significantly 
interacted with risk of dementia (either to a similar or different extent in women and men). 
 
Future prospective studies, with extensive phenotypic and genetic data on risk factors 
common to both diabetes and subtypes of dementia, are needed to examine whether these 
relationships are causal. Moreover, our finding of a greater diabetes-related risk of vascular 
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dementia in women than in men contributes to the growing evidence base that diabetes 
confers a proportionally greater vascular hazard in women than in men. 
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FIGURE LEGEND 
 
Figure 1: Multiple-adjusted relative risk for any dementia, vascular dementia and non-
vascular dementia in women, comparing individuals with diabetes to those without 
diabetes. Horizontal bars represent 95% confidence intervals. RR=relative risk; 
CI=confidence interval. 
 
Figure 2: Multiple-adjusted relative risk for any dementia, vascular dementia and non-
vascular dementia in men, comparing individuals with diabetes to those without diabetes.  
Horizontal bars represent 95% confidence intervals. RR=relative risk; CI=confidence interval. 
 
Figure 3: Multiple-adjusted women to men ratio of relative risks for any dementia, 
vascular dementia and non-vascular dementia, comparing individuals with diabetes to 
those without diabetes.  
Horizontal bars represent 95% confidence intervals. RRR= women to men ratio of relative 
risk; CI=confidence interval. 
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Table 1: Characteristics of included studies 
Cohort Country Baseline 
study 
(years) 
Mean FU 
(years) 
Age 
range 
(years)  
N      
(% w) 
N 
diabetes 
(% w) 
N 
dementia  
(% w) 
N VaD (% 
w) 
N non-
VaD  (% 
w) 
Ascertainment 
of diabetes 
Ascertainment 
of dementia 
Maximum 
adjustment 
available 
ACT Study
18
 US 1994-96 7 65+  2067 (59)  232 (52)  524 (62)  67 (61)  457 (62)  Measured Cognitive 
Abilities 
Screening 
Instrument, 
DSM, 
NINCDS/ADRDA 
Age, sbp, 
smoking, bmi  
ARIC
15
 US 1990-92 14 46-70 11151 
(57)  
1445 (55)  203 (57)  NA NA Measured or 
SR 
ICD-9 codes  Age, race, sbp, 
smoking, bmi, tc 
CCMS
20
 US 1995 5 65+ 3260 (58)  343 (53)  141 (71)  37 (65)  104 (73)  SR DSM, 
NINCDS/ADRDA,  
NINDS-AIREN 
Age, 
hypertension, 
bmi, high 
cholesterol 
English and 
Scottish 
Health 
surveys
16
 
UK 1998-08 8 16-102 154844 
(52)  
12267 
(48)  
1242 (54)  NA NA SR ICD-9, ICD-10 
codes  
Age, sbp, 
smoking, bmi, tc 
Framingham 
Study
14
 
US 1976-78 13 NR 2609 (56)  363 (43)  234 (61)  51 (61)  183 (61)  Measured DSM, 
NINCDS/ADRDA, 
NINDS-AIREN 
Age, sbp, 
smoking, bmi, tc 
Hisayama 
Study
23
 
Japan 1985-88 15 60+ 1017 (57)  150 (55)  232 (66)  65 (51)  167 (72)  Measured DSM, 
NINCDS/ADRDA,  
NINDS-AIREN 
Age, sbp, 
smoking, bmi, tc 
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Cohort Country Baseline 
study 
(years) 
Mean FU 
(years) 
Age 
range 
(years)  
N      
(% w) 
N 
diabetes 
(% w) 
N 
dementia  
(% w) 
N VaD 
 (% w) 
N non-
VaD  (% 
w) 
Ascertainment 
of diabetes 
Ascertainment 
of dementia 
Maximum 
adjustment 
available 
Kame Project
17
 US 1992-
1994 
6 65+ 1709 (55)  290 (44)  140 (59)  45 (58)  112 (63)  SR DSM, 
NINCDS/ADRDA, 
NINDS-AIREN 
Age, sbp, 
smoking, bmi 
Kungsholmen 
Project
25
 
Sweden 1987-89 9 75+ 1301 (75)  104 (75)  350 (81)  49 (71)  301 (83)  SR DSM, 
NINCDS/ADRDA,  
NINDS-AIREN 
Age, sbp, 
smoking, bmi  
MHAS
22
 Mexico 2001-03 3 60 + 5398 (54) 749 (61) 306 (60) 54 (63) 230 (61) SR CCCE, IQCODE Age, 
hypertension, 
smoking, obesity 
NHI, Taiwan
12
 Taiwan 2000-08 9 NR 1229747 
(52)  
614876 
(52)  
95087 
(57)  
8300 (52)  86757 
(57)  
Measured ICD-9 codes  Age, insurance 
premium, region, 
urbanization 
cbvd, cvd, 
hypertension, 
hyperlipidemia 
NHIC, Korea
6
 Korea 1992-95 14 40-95 848505 
(42)  
51611 
(35)  
2914 (55)  516 (47)  1669 (57)  Measured DSM and 
medical 
examination 
Age, alcohol 
Norwegian 
Counties 
Study
24
 
Norway 1974-78 35 35-50 46231 
(51)  
613 (34)  460 (53)  NA NA Measured or 
SR 
ICD-9 codes  Age, sbp, 
smoking, bmi, tc 
OCTO-Twin 
Study
19, 21
 
Sweden 1991-99 9 80+ 702 (67)  122 (67)  225 (70)  57 (58)  163 (73)  Measured DSM, 
NINCDS/ADRDA,  
NINDS-AIREN 
Age, sbp, 
smoking, bmi, tc 
SALSA Study
21
 US 1998-99 10 60+ 1789 (58)  797 (56)  116 (66)  12 (50)  90 (71)  Measured or 
SR 
DSM, 
NINCDS/ADRDA,  
Age, sbp, 
smoking, bmi, tc 
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28 
 
Study abbreviations: %w; percent women; ACT, Adult Changes in Thought; ARIC, Atherosclerosis Risk in Communities Study; CCMS, Cache 
County Memory Study; MHAS, Mexican Health and Aging Study; NHI, National Health Insurance; NHIC, National Health Insurance Corporation; 
OCTO, Origins of Variance in the Old-Old; SALSA, Sacramento Area Latino Study on Aging. 
Abbreviations: BMI, body mass index; CCCE, Cross-Cultural Cognitive Examination; cbvd, cerebrovascular disease; cvd, cardiovascular disease; 
DSM, Diagnostic and Statistical Manual of Mental Disorders; ICD, International Classification of Disease; IQCODE Informant Questionnaire on 
COgnitive Decline in the Elderly; NA, not available; NINCDS/ADRDA, National Institute of Neurological and Communicative Disorders and Stroke 
and the Alzheimer's Disease and Related Disorders Association criteria; NINDS-AIREN, National Institute of Neurological Disorders and Stroke 
and Association Internationale pour la Recherché et l'Enseignement en Neurosciences criteria; sbp, systolic blood pressure; tc, total 
cholesterol, VaD, Vascular Dementia; SR, self-report diabetes; UK, United Kingdom; US, United States of America.  
NINDS-AIREN 
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All dementia
Subtotal  (I-squared = 0.0%, p = 0.650)
Vascular dementia
Subtotal  (I-squared = 33.9%, p = 0.137)
Non-vascular dementia
Subtotal  (I-squared = 29.9%, p = 0.161)
English and Scottish Health surveys
ACT Study
Hisayama Study
Kungsholmen Project
NHIC Korea
MHAS
OCTO-Twin Study
NHI, Taiwan
Kame project
SALSA Study
Framingham Study
CCMS
Norwegian Counties Study
ARIC
Framingham Study
MHAS
ACT Study
NHI, Taiwan
Hisayama Study
NHIC Korea
Kungsholmen Project
OCTO-Twin Study
Kame project
CCMS
MHAS
ACT Study
Hisayama Study
CCMS
NHIC Korea
OCTO-Twin Study
Kungsholmen Project
NHI, Taiwan
Kame project
SALSA Study
Framingham Study
Study
1.15 (0.68, 1.92)
1.23 (0.86, 1.76)
1.51 (0.97, 2.35)
1.57 (1.06, 2.34)
1.60 (1.40, 1.90)
1.61 (1.03, 2.51)
1.66 (1.14, 2.43)
1.68 (1.65, 1.72)
1.77 (0.93, 3.38)
1.98 (1.24, 3.15)
2.11 (1.29, 3.46)
2.24 (1.28, 3.73)
2.25 (0.84, 6.07)
2.28 (1.49, 3.49)
1.68 (1.64, 1.71)
1.12 (0.33, 3.76)
1.19 (0.42, 3.47)
1.47 (0.59, 3.63)
2.01 (1.88, 2.15)
2.27 (0.96, 5.35)
2.80 (2.00, 3.90)
2.86 (1.08, 7.60)
3.26 (1.58, 6.74)
3.50 (1.18, 10.35)
5.75 (2.11, 14.41)
2.34 (1.86, 2.94)
0.41 (0.12, 1.37)
1.18 (0.80, 1.74)
1.33 (0.79, 2.24)
1.37 (0.60, 2.74)
1.40 (1.10, 1.70)
1.42 (0.90, 2.24)
1.47 (0.95, 2.27)
1.66 (1.63, 1.69)
1.68 (0.83, 3.41)
1.87 (1.12, 3.10)
2.47 (1.44, 4.24)
1.53 (1.35, 1.73)
RR (95% CI)
0.15
0.32
0.21
0.26
1.78
0.21
0.29
95.90
0.10
0.19
0.17
0.15
0.04
0.23
100.00
3.26
4.21
5.52
37.82
6.04
21.37
4.84
7.96
4.01
4.98
100.00
1.04
8.14
5.14
2.55
18.04
6.39
6.89
38.81
2.93
5.29
4.78
100.00
Weight
%
Diabetes less risky Diabetes more risky 
1.25 .5 2.5 5 10
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All dementia
Subtotal  (I-squared = 37.6%, p = 0.077)
Vascular dementia
Subtotal  (I-squared = 0.0%, p = 0.857)
Non-vascular dementia
Subtotal  (I-squared = 18.5%, p = 0.268)
Kungsholmen Project
Framingham Study
OCTO-Twin Study
Kame project
NHI, Taiwan
ACT Study
NHIC Korea
Hisayama Study
MHAS
CCMS
English and Scottish Health surveys
Norwegian Counties Study
ARIC
SALSA Study
Hisayama Study
Kungsholmen Project
Framingham Study
CCMS
NHI, Taiwan
NHIC Korea
OCTO-Twin Study
Kame project
ACT Study
MHAS
OCTO-Twin Study
MHAS
Kungsholmen Project
Framingham Study
Kame project
ACT Study
NHI, Taiwan
NHIC Korea
Hisayama Study
CCMS
SALSA Study
Study
0.92 (0.35, 1.12)
1.01 (0.58, 1.79)
1.11 (0.59, 2.08)
1.48 (0.80, 2.74)
1.52 (1.50, 1.57)
1.55 (1.05, 2.29)
1.60 (1.30, 1.80)
1.63 (0.94, 2.84)
1.68 (1.00, 2.83)
2.05 (1.03, 3.83)
2.15 (0.95, 4.89)
2.37 (1.11, 5.05)
2.91 (1.79, 4.74)
3.39 (1.65, 6.95)
1.61 (1.42, 1.83)
1.08 (0.42, 2.83)
1.11 (0.13, 9.45)
1.30 (0.41, 4.08)
1.32 (0.19, 5.49)
1.71 (1.59, 1.83)
2.00 (1.50, 2.80)
2.11 (0.86, 5.19)
2.16 (0.80, 5.86)
2.62 (1.01, 6.79)
3.62 (1.01, 13.03)
1.73 (1.61, 1.85)
0.67 (0.26, 1.70)
0.69 (0.25, 1.88)
0.92 (0.30, 2.79)
0.94 (0.49, 1.80)
1.23 (0.58, 2.60)
1.39 (0.91, 2.13)
1.51 (1.48, 1.55)
1.60 (1.30, 2.00)
2.16 (1.08, 4.29)
2.33 (0.95, 5.17)
2.57 (1.11, 5.97)
1.49 (1.31, 1.69)
RR (95% CI)
4.15
4.38
3.61
3.74
29.86
7.94
20.22
4.49
4.99
3.36
2.24
2.59
5.59
2.85
100.00
0.50
0.10
0.35
0.16
92.40
4.69
0.57
0.46
0.50
0.28
100.00
1.75
1.53
1.26
3.53
2.68
7.50
53.22
21.06
3.17
2.14
2.17
100.00
Weight
%
Diabetes less risky Diabetes more risky 
1.25 .5 2.5 5 10
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All dementia
Subtotal  (I-squared = 0.3%, p = 0.444)
Vascular dementia
Subtotal  (I-squared = 0.0%, p = 0.584)
Non-vascular dementia
Subtotal  (I-squared = 24.0%, p = 0.215)
English and Scottish Health surveys
SALSA Study
ARIC
ACT Study
Hisayama Study
Norwegian Counties Study
MHAS
NHIC Korea
CCMS
NHI, Taiwan
Kame project
OCTO-Twin Study
Kungsholmen Project
Framingham Study
MHAS
ACT Study
Framingham Study
NHI, Taiwan
NHIC Korea
OCTO-Twin Study
Kame project
Hisayama Study
Kungsholmen Project
CCMS
CCMS
MHAS
Hisayama Study
SALSA Study
ACT Study
NHIC Korea
NHI, Taiwan
Kame project
Kungsholmen Project
OCTO-Twin Study
Framingham Study
Study
UK
US
US
US
Japan
Norway
Mexico
Korea
US
Taiwan
US
Sweden
Sweden
US
Mexico
US
US
Taiwan
Korea
Sweden
US
Japan
Sweden
US
US
Mexico
Japan
US
US
Korea
Taiwan
US
Sweden
Sweden
US
Country
154844 (52)
1789 (58)
11151 (57)
2067 (59)
1017 (57)
46231 (51)
5398 (54)
848505 (42)
3260 (58)
1229747 (52)
1709 (55)
702 (67)
1301 (75)
2609 (56)
5398 (54)
2067 (59)
2609 (56)
1229747 (52)
848505 (42)
702 (67)
1709 (55)
1017 (57)
1301 (75)
3260 (58)
3260 (58)
5398 (54)
1017 (57)
1789 (58)
2067 (59)
848505 (42)
1229747 (52)
1709 (55)
1301 (75)
702 (67)
2609 (56)
(% women)
N
1242 (54)
116 (66)
203 (57)
524 (62)
232 (66)
460 (53)
306 (60)
2914 (55)
141 (71)
95087 (57)
140 (59)
225 (70)
350 (81)
234 (61)
54 (63)
67 (61)
51 (61)
8300 (52)
516 (47)
57 (58)
45 (58)
65 (51)
49 (71)
37 (65)
104 (73)
230 (61)
167 (72)
90 (71)
457 (62)
1669 (57)
86757 (57)
112 (63)
301 (83)
163 (73)
183 (61)
(% women)
Dementia
0.53 (0.20, 1.41)
0.58 (0.25, 1.38)
0.78 (0.41, 1.50)
0.79 (0.46, 1.34)
0.92 (0.45, 1.88)
0.95 (0.27, 3.30)
0.96 (0.48, 1.90)
1.00 (0.80, 1.25)
1.09 (0.47, 2.55)
1.11 (1.07, 1.14)
1.20 (0.49, 2.93)
1.50 (0.72, 3.12)
1.71 (0.84, 3.45)
2.09 (0.99, 4.42)
1.10 (1.06, 1.14)
0.33 (0.06, 1.73)
0.56 (0.15, 2.09)
0.86 (0.16, 4.59)
1.18 (1.07, 1.30)
1.40 (0.89, 2.21)
1.55 (0.49, 4.90)
1.62 (0.37, 7.07)
2.09 (0.58, 7.58)
2.58 (0.24, 27.14)
4.36 (0.63, 29.96)
1.19 (1.08, 1.30)
0.59 (0.19, 1.84)
0.59 (0.12, 2.89)
0.62 (0.26, 1.46)
0.73 (0.27, 1.94)
0.85 (0.47, 1.51)
0.88 (0.64, 1.19)
1.10 (1.07, 1.13)
1.37 (0.49, 3.85)
1.60 (0.48, 5.29)
2.12 (0.75, 6.02)
2.63 (1.13, 6.12)
1.04 (0.86, 1.25)
RR (95% CI)
Ratio of
0.15
0.19
0.33
0.50
0.28
0.09
0.30
2.78
0.20
94.22
0.18
0.26
0.28
0.25
100.00
0.32
0.51
0.31
92.69
4.19
0.66
0.40
0.53
0.16
0.24
100.00
2.56
1.37
4.31
3.39
8.53
20.82
46.09
3.09
2.34
3.03
4.46
100.00
Weight
%
Higher RR in men  Higher RR in women 
1.25 .5 2.5 5 10
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 Supplementary Methods: Newcastle - Ottawa Quality Assessment Scale 
Modified from reference 13 
Selection 
S1) Representativeness of the exposed cohort 
a) truly representative of the general population*  
b) somewhat representative of the general population  
c) selected group of users e.g. nurses, volunteers 
d) no description of the derivation of the cohort 
S2) Selection of the non exposed cohort 
a) drawn from the same community as the exposed cohort * 
b) drawn from a different source 
c) no description of the derivation of the non exposed cohort  
S3) Ascertainment of exposure 
a) secure record (measured diabetes only) * 
b) secure record or written self report 
c) written self report 
d) no description 
S4) Demonstration that outcome of interest was not present at start of study 
a) yes * 
b) no 
Comparability 
C1) Comparability of cohorts on the basis of the design or analysis 
a) study controls for age* 
b) study also controls for systolic blood pressure, smoking, body mass index, and total 
cholesterol*  
 
Outcome 
O1) Assessment of outcome  
a) independent blind assessment of dementia and subtypes*  
b) record linkage of dementia and subtypes* 
c) self report  
d) no description 
O2) Was follow-up long enough for outcomes to occur 
a) yes (at least 10 years) * 
b) no 
O3) Adequacy of follow up of cohorts 
a) complete follow up - all subjects accounted for * 
b) subjects lost to follow up unlikely to introduce bias - > 10% follow up, or description provided 
 of those lost * 
c) follow up rate < 90% and no description of those lost 
d) no statement 
        Studies get a point for each * 
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Supplementary references 
Note: In italics are the references to studies that had multiple reports from the same study.  
1. Ahtiluoto S, Polvikoski T, Peltonen M, et al. Diabetes, Alzheimer disease, and vascular 
dementia: a population based neuropathologic study. Neurology. 2010;75(13): 1195–1202. 
2. Al-Emam A, Elhaddad AA, Ramadan E, et al. The risk of clinically diagnosed Alzheimer disease 
in patients with noninsulin dependent diabetes mellitus. Egypt J Neurol Psychiat Neurosurg. 
2010;47(1):419–424. 
3. Arvanitakis Z, Wilson RS, Bienias JL, et al. Diabetes mellitus and risk of Alzheimer disease and 
decline in cognitive function. Arch Neurol. 2004;61(5):661–666. 
4. Brayne C, Gill C, Huppert FA, et al. Vascular risks and incident dementia: results from a 
cohort study of the very old. Dement Geriatr Cogn Disord. 1998;9(3):175–180. 
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2008; 65: 89–93. 
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Supplementary Table 1: Quality assessment of the included studies 
Study S1 S2 S3 S4 C1 O1 O2 O3  Sum 
ACT Study 1 1 1 1 1 1 0 1  7 
ARIC Study 1 1 0 1 1 1 1 1  7 
CCMS 1 1 0 1 1 1 0 1  6 
English and Scottish Health Surveys 1 1 0 1 2 1 0 0  6 
Framingham Study 1 1 1 1 2 1 1 1  9 
Hisayama Study 1 1 1 1 2 1 1 1  9 
Kame Project 1 1 0 1 1 1 0 1  6 
Kungsholmen Project 1 1 0 1 1 1 0 1  6 
MHAS 1 1 0 1 1 1 0 1  6 
NHI, Taiwan 1 1 1 1 1 1 0 1  7 
NHIC, Korea 1 1 1 1 1 1 1 1  8 
Norwegian Counties Study  1 1 0 1 2 1 1 1  8 
OCTO-Twin Study 0 1 1 1 2 1 0 1  7 
SALSA  1 1 0 1 2 1 1 1  8 
 
A description of the items for quality assessment is provided in the Supplementary methods 
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Supplementary Table 2: Incidence of dementia per 1000 person years by sex and diabetes status 
 Women Men Differences 
 Diabetes No 
diabetes 
Diabetes No 
diabetes 
Women Men Women-
Men 
Any dementia        
ACT Study 34.75 36.38 39.63 32.4 -1.63 7.23 -8.86 
ARIC 3.5 1.12 3.37 1.17 2.38 2.2 0.18 
CCMS 17.22 12.14 11.75 6.53 5.08 5.22 -0.14 
English and Scottish Health surveys 1.69 0.85 1.19 0.66 0.84 0.53 0.31 
Framingham Study 17.53 11.28 11.25 10.46 6.25 0.79 5.46 
Hisayama Study 29 21.32 23.46 15.3 7.68 8.16 -0.48 
Kame project 22.76 13.03 17.03 11.39 9.73 5.64 4.09 
Kungsholmen Project 104.3 65.61 51.65 46.11 38.69 5.54 33.15 
MHAS 7.39 24.26 5.21 19.26 -16.87 -14.05 -2.82 
NHI, Taiwan 13.38 8.71 10.97 7.52 4.67 3.45 1.22 
NHIC Korea NA NA NA NA NA NA NA 
Norwegian Counties Study 0.705 0.326 0.683 0.319 0.379 0.364 0.015 
OCTO-Twin Study 91.46 49.84 47.24 46.13 41.62 1.11 40.51 
SALSA Study 13.74 10.34 11.99 5.44 3.4 6.55 -3.15 
        
Vascular dementia        
ACT Study 5.21 4.45 8.16 3.75 0.76 4.41 -3.65 
CCMS 10.6 2.23 2.94 2.18 8.37 0.76 7.61 
Framingham Study 2.63 2.59 3.52 2.06 0.04 1.46 -1.42 
Hisayama Study 8.12 4.33 7.33 6.56 3.79 0.77 3.02 
Kame project 9.37 3.75 7.61 3.33 5.62 4.28 1.34 
Kungsholmen Project 18.63 7.66 10.33 9.99 10.97 0.34 10.63 
NHI, Taiwan 1.23 0.56 1.19 0.61 0.67 0.58 0.09 
NHIC Korea NA NA NA NA NA NA NA 
OCTO-Twin Study 30.49 8.65 27.56 14 21.84 13.56 8.28 
SALSA Study 1.06 0.82 2.77 NA 0.24 NA NA 
        
Non-vascular dementia        
ACT Study 29.54 31.93 31.47 28.65 -2.39 2.82 -5.21 
CCMS 6.62 9.91 8.81 4.36 -3.29 4.45 -7.74 
Framingham Study 14.9 8.69 7.74 8.39 6.21 -0.65 6.86 
Hisayama Study 20.88 16.99 16.13 8.74 3.89 7.39 -3.5 
Kame project 17.4 11.45 10.88 8.62 5.95 2.26 3.69 
Kungsholmen Project 85.68 57.95 41.32 36.12 27.73 5.2 22.53 
NHI, Taiwan 12.15 8.15 9.78 6.91 4 2.87 1.13 
OCTO-Twin Study 61.02 39.13 19.69 32.13 21.89 -12.44 34.33 
SALSA Study 11.63 8.43 6.92 4.6 3.2 2.32 0.88 
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Supplementary Figure 1 
Pooled multiple-adjusted relative risk for any dementia, vascular dementia and non-vascular 
dementia, comparing individuals with diabetes to those without diabetes, with and without 
exclusion of NHI Taiwan and NHIC Korea 
Supplementary Figure 2 
Pooled multiple-adjusted women to men ratio of relative risk for any dementia, vascular dementia 
and non-vascular dementia, comparing individuals with diabetes to those without diabetes, with and 
without exclusion of NHI Taiwan and NHIC Korea 
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Supplementary Figure 1 
.
.
.
Any dementia
Vascular dementia
Non-vascular dementia
All studies
Without NHI Taiwan
Without NHIC Korea
Without NHI Taiwan and NHIC Korea
All studies
Without NHI Taiwan
Without NHIC Korea
Without NHI Taiwan and NHIC Korea
All studies
Without NHI Taiwan
Without NHIC Korea
Without NHI Taiwan and NHIC Korea
Women
Men
Women
Men
Women
Men
Women
Men
Women
Men
Women
Men
Women
Men
Women
Men
Women
Men
Women
Men
Women
Men
Women
Men
Sex
1.68 (1.64, 1.71)
1.61 (1.42, 1.83)
1.64 (1.48, 1.81)
1.66 (1.39, 1.99)
1.68 (1.65, 1.72)
1.63 (1.38, 1.94)
1.67 (1.46, 1.91)
1.68 (1.34, 2.10)
2.34 (1.86, 2.94)
1.73 (1.61, 1.85)
2.58 (1.96, 3.39)
1.94 (1.52, 2.48)
2.21 (1.72, 2.85)
1.71 (1.60, 1.84)
2.43 (1.67, 3.54)
1.86 (1.25, 2.76)
1.53 (1.35, 1.73)
1.49 (1.31, 1.69)
1.45 (1.24, 1.69)
1.42 (1.13, 1.78)
1.55 (1.35, 1.80)
1.42 (1.16, 1.73)
1.47 (1.20, 1.81)
1.34 (0.99, 1.80)
RR (95% CI)
Diabetes less risky Diabetes more risky 
1.75 1.25 1.5 2 2.5 3
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Supplementary Figure 2 
 
.
.
.
Any dementia
Vascular dementia
Non-vascular dementia
All studies
Without NHI Taiwan
Without NHIC Korea
Without NHI Taiwan and NHIC Korea
All studies
Without NHI Taiwan
Without NHIC Korea
Without NHI Taiwan and NHIC Korea
All studies
Without NHI Taiwan
Without NHIC Korea
Without NHI Taiwan and NHIC Korea
1.10 (1.06, 1.14)
1.01 (0.87, 1.18)
1.09 (1.00, 1.19)
1.02 (0.81, 1.28)
1.19 (1.08, 1.30)
1.33 (0.94, 1.88)
1.18 (1.07, 1.30)
1.24 (0.73, 2.11)
1.04 (0.86, 1.25)
1.00 (0.75, 1.34)
1.08 (0.86, 1.36)
1.07 (0.74, 1.56)
RRR (95% CI)
Higher RR in men  Higher RR in women 
1.75 1.25 1.5 2
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